To improve patient care and quality of life, for all.
Biomimicry is looking to nature for inspiration in human technology and design.
Our mission is to harness this natural genius to improve the standard of patient care across the health care spectrum. We aim to increase access and affordability to life-changing medical technologies in areas such as wound care, surgery, eye care, and more—ultimately enhancing life.
Values we live by.
More than just words.
Integrity
We strive to empower clinicians with unwavering commitment to our foundation of scientific evidence, ensuring trust in each innovation we offer.
Quality
Our team is committed to excellence, and our devices meet or exceed the highest industry standards, always ensuring patient safety and optimal performance.
Innovation
We’re passionate about drawing inspiration from nature's brilliance to bring real, safe, and effective medical devices to the health care spectrum.
Sustainability
We're dedicated to environmentally-conscious practices, reducing the eco footprint of our products, and advancing healthcare with a focus on the long-term health of our planet.
Meet The Team
Bill Roberts
President Read BioBill Roberts is a seasoned expert in innovative medical solutions for Canadian healthcare institutions. He founded two prominent medical device distribution companies, Coherent-AMT (now Clarion Medical) and AMT Surgical. Coherent-AMT became the largest medical laser distributor in Canada under Bill's leadership, achieving substantial annual sales growth from under $1M to approximately $60M. In 2011, he sold his shares when the company reached $55M million in annual revenue. AMT Surgical, established in 1992, has become a significant specialty supplier to over 400 hospitals nationwide, generating annual revenue of $100M.
Bill's strong relationships with key stakeholders in the healthcare industry contributed to AMT Surgical's success. After a brief retirement, he launched Xcite Technologies, focusing on sales and service of medical aesthetic equipment and supplies. Bill's passion extends beyond his own ventures as he actively supports early-stage Canadian start-ups, serving on various boards and investing in promising companies like Intellijoint Surgical.
Robert Fuller
Managing Director Read BioRobert Fuller is a serial entrepreneur with diverse experience in startups. He founded the Duke Brothers, a cold brew coffee manufacturer based in Ontario, building strong relationships with notable customers. His innovative approach of using ultrasonic extraction enhanced polyphenol content without compromising flavour.
Robert then established Fade Away Laser—leading the Laser Tattoo Removal market in Ontario and driving consistent revenue growth. In parallel, Robert served as VP of Operations and Regulatory at Xcite Technologies, designing effective marketing strategies for the Canadian market and expanding the online sales channel. Here, he played a key role in obtaining regulatory approvals for medical devices.
Robert then co-founded Sterasure Inc. along with Bill Roberts, focusing on the infection prevention and control industry. Rob's expertise in healthcare enables him to address the unique challenges faced by healthcare groups with IPAC protocols.
In particular, Robert's expertise in the formulation, production and scientific foundation of pure, stable hypochlorous acid (HOCl) enables Biomiq to charge forward in advancing patient care.
Throughout his career, Robert has relentlessly proven his entrepreneurial acumen, identifying opportunities, building successful ventures, and navigating complex industries.
Tom Pejkovic
Director of Finance & OperationsRyan Hanes
Director of Product MarketingRobert Lamont
Lead ChemistKaren Mikula
Sales Representative, Southern Ontario Read BioKaren's educational background in Microbiology and Chemical Engineering Technology and her passion for people and healthcare inspire her everyday to share this knowledge with healthcare providers and inspire her sales team.
Karen provides sales and clinical support to healthcare professionals, supply chain leaders, procurement specialists, LTC organizations, and family health teams within the Ontario and Manitoba healthcare systems.
Karen has a proven track record in sales expertise and brings this acumen to Biomiq with the sole purpose of helping clinicians improve patient outcomes.
Brooke Thompson
Territory Sales Manager, OntarioLana Nguyen
Territory Sales Manager, OntarioTodd Taylor
Sales Representative, Atlantic CanadaLorry Prokopich
Sales Representative, British ColumbiaMarianne Stacey
Business Development Read BioMarianne has an international executive leadership background in the Medical Device industry, she has served in various capacities including as Director of Sales & Marketing Development, specializing in wound care for many years.
In transitioning to a business development focus, Marianne advises startups and contributes to growth with a focus on enhancing solutions that contribute to patients' healing journeys.
T.J. Andersson
Clinical Educator & Sales ConsultantMatt Schabl
Logistics & Warehouse ManagerLiz Walker
Customer Success ManagerMeet Our Advisory Board
Dr. Liza Ovington
Ph.D. | Scientific Advisor Read BioDr. Liza Ovington received her Ph.D. in synthetic organic chemistry from Duke University in 1986 and worked in wound care product development research at Johnson & Johnson for 5 years before leaving to pursue clinical and preclinical research in wound healing at the University of Miami School of Medicine in the Department of Dermatology & Cutaneous Surgery. She subsequently developed and managed wound and continence specialty care programs for a national home healthcare agency, was board certified by the American Board of Wound Management in 1995 and served as their President and on their Board.
Liza is currently a Fellow of the American College of Certified Wound Specialists, a diplomate of the American Professional Wound Care Association, achieved certification in medical writing from the American Medical Writers Association and has served on the editorial boards for several wound care journals. She was president of her own wound care consulting company from 1995 through 2004 where her clients included companies such as Coloplast, ConvaTec, DuPont , Ferndale Laboratories, HealthPoint, KCI, Medline, Molnlycke, Urgo Laboratories, Smith & Nephew, and Westaim Biomedical. She rejoined Johnson and Johnson in late 2004 in the Ethicon Medical Affairs department with responsibility for wound closure, wound healing and infection prevention. She retired from Ethicon in 2020 and is again consulting in the areas of wound management, infection prevention, and chemistry.
Dr. Eric Rasmussen
MD, MDM, FACP | Medical Advisor Read BioDr. Eric David Rasmussen is the CEO of Infinitum Humanitarian Systems in Seattle, Washington. He is an internal medicine physician with both undergraduate and medical degrees from Stanford University and a European Master’s degree in disaster medicine from the UN World Health Organization’s affiliate CEMEC (Centre European pour la Médecins des Catastrophes) in Italy. He was elected a Fellow of the American College of Physicians in 1997 and a National Fellow of the Explorers Club in 2014.
Rasmussen served in the U.S. Navy for 25 years aboard nuclear submarines, amphibious ships, and aircraft carriers, with positions that included:
- Joint Task Force Surgeon (Forward) for the Hurricane Katrina response;
- Team Lead for the Banda Aceh Tsunami Response from the Office of the Secretary of Defense;
- Fleet Surgeon for the US Navy’s Third Fleet, responsible for the eastern Pacific;
- Director of an Intensive Care Unit; and,
- Chairman of an academic Department of Medicine in Seattle.
His wartime deployments included Bosnia three times, Afghanistan twice, and Iraq for nine months. While in uniform, Dr. Rasmussen was appointed a Principal Investigator by DARPA, the Defense Advanced Research Projects Agency. His work led to his selection as DARPA’s Principal Investigator of the Year in 2003.
After retiring from the Navy he was appointed the Founding CEO of the TED Prize awarded to Dr. Larry Brilliant, then Executive Director of Google.org. In addition to his current work in the Marshall Islands, Ukraine, Yemen, and the Yucatan rainforest, Rasmussen also leads the Global Disaster Response Team for the Roddenberry Foundation, supported by the Star Trek franchise. That team has deployed to Supertyphoon Haiyan in the Philippines, the Nepal earthquake, Hurricane Mathew in Haiti, three times to Puerto Rico after Hurricane Maria, and to Ukraine in 2022.
Rasmussen also served as the founding Chief Medical Officer for Briotech, co-authoring both the “Handbook of HOCl” and the UN’s WHO Essential Medicines List application for hypochlorous acid. During the SARS-CoV-2 pandemic he coordinated the independent laboratory testing of Briotech’s HOCl for the US EPA and FDA.
He is currently the research director for the Kwajalein Atoll Sustainability Laboratory in the Marshall Islands, and a Member of the Loomis Council at the Stimson Center in DC. He is a former Fellow at the Atlantic Council, the Institute for Human-Machine Cognition, and the Rocky Mountain Institute. In 2012 he was appointed a member of the US National Academy of Science’s Committee on Grand Challenges in Global Development.
Read more about Dr. Rasmussen here: https://en.wikipedia.org/wiki/Eric_Rasmussen_(physician)
Dr. Lori Robins
Ph.D., BS | Scientific Advisor Read BioDr. Lori Robins, PhD, BS, is a Professor of Chemistry at the University of Washington Bothell. She received a BS in Biochemistry from Brandeis University and a PhD in Bioorganic Chemistry from the University of California, Davis. She also studied lipid biochemistry as a postdoctoral researcher at Duke University, Durham, NC. Prior to coming to the University of Washington Bothell, she was an Assistant Professor at California Polytechnic State University, San Luis Obispo, CA.
Lori has received funding from the National Science Foundation (NSF) and the National Institute of Allergy and Infectious Diseases (NIAID) division of the National Institutes of Health (NIH). She has 25 peer-reviewed publications and has presented her work at international conferences on infectious disease research.
Lori has worked on projects related to HOCl since 2015.
Dr. Michael Stacey
MBBS, DS, FRACS | Clinical & Research Advisor Read BioDr. Michael Stacey is a renowned vascular surgeon who came to Canada from Australia in 2014 as the Surgeon in Chief at Hamilton Health Sciences and Professor in the Department of Surgery at McMaster University.
He completed his medical degree at the University of Western Australia, is a Fellow of the Royal Australasian College of Surgeons, and has a Doctor of Surgery degree (PhD equivalent).
Dr. Stacey took on the role as Chief Medical Executive and Executive Vice President Academic at Hamilton Health Sciences in 2018 until mid-2023.
In addition to his practice in vascular surgery, Dr. Stacey has established active research programs in wound healing in both Australia and in Canada. He was the first President of the Australian Wound Management Association (now Wounds Australia), and the founding Chair of the World Union of Wound Healing Societies.
Dr. Stacey has a passion for advancing wound care for patients. He has previously established a multidisciplinary diabetic foot ulcer clinic and a venous leg ulcer clinic in Australia and is currently working to establish similar clinics in Canada.
Dr. Jeff Williams
Ph.D. | Scientific Advisor Read BioDr. Jeff Williams had a long career in academic microbiology and infectious diseases, retiring after 27 years from his position as Professor of Microbiology and Molecular Genetics at Michigan State University to found a biotechnology start-up, HaloSource Inc, in Seattle, WA in 1998. Retiring, again, in 2014, he has remained active as technical advisor to several companies in the PNW region, specializing in the areas of antimicrobial chemistry and disinfection.
Author of over 200 scientific papers and textbook chapters , he served four years as a member of the Board of Counselors to the US-NIH Institute of Allergy and Infectious Diseases, and has been a frequent consultant to the World Health Organisation of the UN in Geneva, Switzerland. Jeff was elected Fellow of the American Association for the Advancement of Science (AAAS) in 1996, and served as retained consultant to first Merck Inc. (1980-82), then Pharmacia (now Pfizer Inc.) (1983-1999) on therapeutic drug discovery and development. He has a long standing interest in tropical infectious diseases, starting with his appointment as staff scientist for WHO in Argentina 1968-71, and for 15 years directed a collaborative NIH-funded Program Project on Infectious Diseases in Sudan. He holds degrees in Veterinary Science (B.V.Sc., University of Bristol, UK, 1964), and Pathobiology (Ph.D, University of Pennsylvania, 1968), where he was a Fulbright Scholar (1964-68).
Let’s talk.
Connect 1-on-1 with one of our specialists and let them tailor a game plan designed specifically for your clinic or institution.
Get StartedFrom the Team
Stay up-to-date on the latest insights from the world of infection prevention medical technologies and tools. In our blog, we explore the relationship between these technologies, the science behind them, and the perspectives that matter to patients and clinicians alike.
Explore the Blog